plateled/ lymphocyt ratio as prognostic valeu in prostate cancer
Prognostic role of platelet-to-lymphocyte ratio and neutrophil-to-lymphocyte ratio in patients with metastatic castration resistant prostate cancer treated with abiraterone or enzalutamide / Sciarra, A.; Gentilucci, A.; Cattarino, S.; Salsiccia, S.; Mariotti, G.. - In: MINERVA UROLOGY AND NEPHROLOGY. - ISSN 2724-6051. - 73:6(2022), pp. 863-865. [10.23736/S2724-6051.21.04814-X]
Prognostic role of platelet-to-lymphocyte ratio and neutrophil-to-lymphocyte ratio in patients with metastatic castration resistant prostate cancer treated with abiraterone or enzalutamide
Sciarra A.;Gentilucci A.;Cattarino S.;
2022
Abstract
plateled/ lymphocyt ratio as prognostic valeu in prostate cancerFile allegati a questo prodotto
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.